Inherited cylindromas: Lessons from a rare tumour

The Lancet Oncology

Volumn 16, Issue 9, 2015, Pages e460-e469

  Rajan, Neil ^a   Ashworth, Alan ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CYLD; TUMOR PROTEIN; UNCLASSIFIED DRUG; CYLD PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADENOID CYSTIC CARCINOMA; CANCER SURGERY; CLINICAL FEATURE; CYLD GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GERMLINE MUTATION; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MOUSE MODEL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RARE DISEASE; REVIEW; SEXUAL DYSFUNCTION; TRICHOEPITHELIOMA; TUMOR GENE; CARCINOMA, ADENOID CYSTIC; GENETICS; PATHOLOGY; PHENOTYPE; SKIN NEOPLASMS;

CARCINOMA, ADENOID CYSTIC; GENETIC COUNSELING; GERM-LINE MUTATION; HUMANS; PHENOTYPE; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84940533732     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00245-4     Document Type: Review

References (78)

1. Massoumi R, Podda M, Fässler R, Paus R Cylindroma as tumor of hair follicle origin. J Invest Dermatol 2006, 126:1182-1184.
2. Rajan N, Langtry JA, Ashworth A, et al. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction. Arch Dermatol 2009, 145:1277-1284.
3. Biggs PJ, Wooster R, Ford D, et al. Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet 1995, 11:441-443.
4. Bignell GR, Warren W, Seal S, et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000, 25:160-165.
5. Knudson AG Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823.
6. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424:797-801.
7. Kovalenko A, Chable-Bessia C, Cantarella G, Israël A, Wallach D, Courtois G The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003, 424:801-805.
8. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003, 424:793-796.
9. Kuphal S, Shaw-Hallgren G, Eberl M, et al. GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma. Oncogene 2011, 30:4523-4530.
10. Massoumi R Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci 2010, 35:392-399.
11. Cotton DW, Braye SG Dermal cylindromas originate from the eccrine sweat gland. Br J Dermatol 1984, 111:53-61.
12. Michal M, Lamovec J, Mukensnabl P, Pizinger K Spiradenocylindromas of the skin: tumors with morphological features of spiradenoma and cylindroma in the same lesion: report of 12 cases. Pathol Int 1999, 49:419-425.
13. Evans CD Turban tumour. Br J Dermatol 1954, 66:434-443.
14. Fabian RL, Shugar MA Florid dermal cylindroma (turban tumor). Head Neck Surg 1981, 4:165-169.
15. Linos K, Schwartz J, Kazakov DV, Vanecek T, Carlson JA Recurrent CYLD nonsense mutation associated with a severe, disfiguring phenotype in an African American family with multiple familial trichoepithelioma. Am J Dermatopathol 2011, 33:640-642.
16. Grossmann P, Vanecek T, Steiner P, et al. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Am J Dermatopathol 2013, 35:34-44.
17. Bilroth T Die cylindergeschwulst (cylindroma). Untersuchungen über die Entwicklung der Blutgefässe, nebst Beobachtungen aus der königlichen chirurgischen Universitäts-Klinik zu Berlin 1856, 55-69. G Riemer, Germany.
18. Bruckner-Tuderman L, Pfaltz M, Schnyder UW Cylindroma overexpresses collagen VII, the major anchoring fibril protein. J Invest Dermatol 1991, 96:729-734.
19. Tunggal L, Ravaux J, Pesch M, et al. Defective laminin 5 processing in cylindroma cells. Am J Pathol 2002, 160:459-468.
20. Rajan N, Burn J, Langtry J, Sieber-Blum M, Lord CJ, Ashworth A Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression. J Pathol 2011, 224:309-321.
21. Arwert EN, Hoste E, Watt FM Epithelial stem cells, wound healing and cancer. Nat Rev Cancer 2012, 12:170-180.
22. Crain RC, Helwig EB Dermal cylindroma (dermal eccrine cylindroma). Am J Clin Pathol 1961, 35:504-515.
23. Sellheyer K Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers. J Cutan Pathol 2015, 42:90-101.
24. Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fässler R Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 2006, 125:665-677.
25. Pahl HL Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
26. Blaschko A. Die Nevenverteilung in derhant in ihrer Beziehung zuden Ekrankungender Haut. Verhand Deust Dermatol Gessel. VII Congress; Breslan; May 1901.
27. Saunders H, Tucker P, Saurine T, Watkins F Pedigree of multiple benign adnexal tumours of Brooke-Spiegler type. Australas J Dermatol 2003, 44:144-148.
28. Happle R Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 1996, 66:241-242.
29. Headington JT, Batsakis JG, Beals TF, Campbell TE, Simmons JL, Stone WD Membranous basal cell adenoma of parotid gland, dermal cylindromas, and trichoepitheliomas. Comparative histochemistry and ultrastructure. Cancer 1977, 39:2460-2469.
30. Jungehülsing M, Wagner M, Damm M Turban tumour with involvement of the parotid gland. J Laryngol Otol 1999, 113:779-783.
31. Hyman BA, Scheithauer BW, Weiland LH, Irons GB Membranous basal cell adenoma of the parotid gland. Malignant transformation in a patient with multiple dermal cylindromas. Arch Pathol Lab Med 1988, 112:209-211.
32. Nonaka D, Rosai J, Spagnolo D, Fiaccavento S, Bisceglia M Cylindroma of the breast of skin adnexal type: a study of 4 cases. Am J Surg Pathol 2004, 28:1070-1075.
33. Mahmoud A, Hill DH, O'Sullivan MJ, Bennett MW Cylindroma of the breast: a case report and review of the literature. Diagn Pathol 2009, 4:30.
34. Vernon HJ, Olsen EA, Vollmer RT Autosomal dominant multiple cylindromas associated with solitary lung cylindroma. J Am Acad Dermatol 1988, 19:397-400.
35. van Balkom ID, Hennekam RC Dermal eccrine cylindromatosis. J Med Genet 1994, 31:321-324.
36. Gerretsen AL, Beemer FA, Deenstra W, Hennekam FA, van Vloten WA Familial cutaneous cylindromas: investigations in five generations of a family. J Am Acad Dermatol 1995, 33:199-206.
37. Gerretsen AL, van der Putte SC, Deenstra W, van Vloten WA Cutaneous cylindroma with malignant transformation. Cancer 1993, 72:1618-1623.
38. Durani BK, Kurzen H, Jaeckel A, Kuner N, Naeher H, Hartschuh W Malignant transformation of multiple dermal cylindromas. Br J Dermatol 2001, 145:653-656.
39. Kazakov DV, Zelger B, Rütten A, et al. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Am J Surg Pathol 2009, 33:705-719.
40. Schulz T, Proske S, Hartschuh W, Kurzen H, Paul E, Wünsch PH High-grade trichoblastic carcinoma arising in trichoblastoma: a rare adnexal neoplasm often showing metastatic spread. Am J Dermatopathol 2005, 27:9-16.
41. Melly L, Lawton G, Rajan N Basal cell carcinoma arising in association with trichoepithelioma in a case of Brooke-Spiegler syndrome with a novel genetic mutation in CYLD. J Cutan Pathol 2012, 39:977-978.
42. Zuo Y-G, Xu Y, Wang B, et al. A novel mutation of CYLD in a Chinese family with multiple familial trichoepithelioma and no CYLD protein expression in the tumour tissue. Br J Dermatol 2007, 157:818-821.
43. Nijman SMB, Luna-Vargas MPA, Velds A, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005, 123:773-786.
44. Ikeda F, Dikic I Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. EMBO Rep 2008, 9:536-542.
45. Komander D, Lord CJ, Scheel H, et al. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 2008, 29:451-464.
46. Reiley WW, Jin W, Lee AJ, et al. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses. J Exp Med 2007, 204:1475-1485.
47. Tauriello DVF, Haegebarth A, Kuper I, et al. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl. Mol Cell 2010, 37:607-619.
48. Lim JH, Jono H, Komatsu K, et al. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt. Nat Commun 2012, 3:771.
49. Rajan N, Elliott RJR, Smith A, et al. The cylindromatosis gene product, CYLD, interacts with MIB2 to regulate Notch signalling. Oncotarget 2014, 5:12126-12140.
50. Hutti JE, Shen RR, Abbott DW, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell 2009, 34:461-472.
51. Zhang J, Stirling B, Temmerman ST, et al. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest 2006, 116:3042-3049.
52. Trompouki E, Tsagaratou A, Kosmidis SK, et al. Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation. Neoplasia 2009, 11:469-476.
53. Hövelmeyer N, Wunderlich FT, Massoumi R, et al. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med 2007, 204:2615-2627.
54. Urbanik T, Boger RJ, Longerich T, et al. Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. J Hepatol 2012, 57:995-1003.
55. Blake PW, Toro JR Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat 2009, 30:1025-1036.
56. Reiley WW, Zhang M, Jin W, et al. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol 2006, 7:411-417.
57. Hövelmeyer N, Wunderlich FT, Massoumi R, et al. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD. J Exp Med 2007, 204:2615-2627.
58. Srokowski CC, Masri J, Hövelmeyer N, et al. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function. Blood 2009, 113:5891-5895.
59. Harada H, Hashimoto K, Ko Ms The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol 1996, 107:41-43.
60. Vanecek T, Halbhuber Z, Kacerovska D, et al. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma. Am J Dermatopathol 2014, 36:868-874.
61. Kazakov DV, Thoma-Uszynski S, Vanecek T, Kacerovska D, Grossmann P, Michal M A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Am J Dermatopathol 2009, 31:664-673.
62. Nagy N, Rajan N, Farkas K, Kinyó A, Kemény L, Széll M A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds. Acta Derm Venereol 2013, 93:743-745.
63. Jacyk WK, Isaac F A grossly disfiguring case of epithelioma adenoides cysticum in an African. Clin Exp Dermatol 1980, 5:421-423.
64. Salhi A, Bornholdt D, Oeffner F, et al. Multiple familial trichoepithelioma caused by mutations in the cylindromatosis tumor suppressor gene. Cancer Res 2004, 64:5113-5117.
65. Rajan N, Elliott R, Clewes O, et al. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene 2011, 30:4243-4260.
66. Stenn KS, Paus R Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494.
67. Harwood CA, McGregor JM, Swale VJ, et al. High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients. J Am Acad Dermatol 2003, 48:401-408.
68. Fehr A, Kovács A, Löning T, Frierson H, van den Oord J, Stenman G The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol 2011, 224:322-327.
69. Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009, 106:18740-18744.
70. Ivanov SV, Panaccione A, Brown B, et al. TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene 2013, 32:3698-3710.
71. Stephens PJ, Davies HR, Mitani Y, et al. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 2013, 123:2965-2968.
72. Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015, 43:D805-D811.
73. Kobayashi T, Masoumi KC, Massoumi R Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. Oncogene 2015, 34:2251-2260.
74. Pannem RR, Dorn C, Ahlqvist K, Bosserhoff AK, Hellerbrand C, Massoumi R CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis 2014, 35:461-468.
75. Rajan N, Trainer AH, Burn J, Langtry JA Familial cylindromatosis and brooke-spiegler syndrome: a review of current therapeutic approaches and the surgical challenges posed by two affected families. Dermatol Surg 2009, 35:845-852.
76. Rahim RR, Rajan N, Langtry JA Infiltrative recurrent eccrine spiradenoma of the anterior neck treated using Mohs micrographic surgery. Dermatol Surg 2013, 39:1711-1714.
77. Oosterkamp HM, Neering H, Nijman SMB, et al. An evaluation of the efficacy of topical application of salicyclic acid for the treatment of familial cylindromatosis. Br J Dermatol 2006, 155:182-185.
78. Baden HP Cylindromatosis simulating neurofibromatosis. N Engl J Med 1962, 267:296-297.